Plasma histamine levels (H) during adjunctive H₁-receptor antagonist treatment with loratadine in patients with active Inflammatory Bowel disease (IBD)

Issue Title: Papers given at the 38th annual meeting of the European Histamine Research Society, Fulda (Germany), May 13-16, 2009

Saved in:
Bibliographic Details
Published in:Inflammation research 2010-03, Vol.59 (2), p.257-258
Main Authors: Raithel, M, Nägel, A, Zopf, Y, deRossi, Th, Stengel, Ch, Hagel, A, Kressel, J, Hahn, E. G, Konturek, P
Format: Article
Language:English
Subjects:
Allergology
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Biomedical and Life Sciences
Biomedicine
Colitis, Ulcerative - blood
Colitis, Ulcerative - drug therapy
Crohn Disease - blood
Crohn Disease - drug therapy
Dermatology
Histamine - blood
Histamine H1 Antagonists - therapeutic use
Humans
Immunology
Inflammatory bowel disease
Inflammatory Bowel Diseases - blood
Inflammatory Bowel Diseases - drug therapy
Loratadine - therapeutic use
Mesalamine - therapeutic use
Neurology
Pharmacology/Toxicology
Prednisolone - therapeutic use
Rheumatology
Short Communication
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Issue Title: Papers given at the 38th annual meeting of the European Histamine Research Society, Fulda (Germany), May 13-16, 2009
ISSN:1023-3830
1420-908X
DOI:10.1007/s00011-009-0120-9